Expertise in
22
conditions

Dr. Karthik Koduru

Oncology
Quincy Medical Group Cancer Institute
3301 Broadway St, 
Quincy, IL 
Expertise in
22
conditions
Quincy Medical Group Cancer Institute
3301 Broadway St, 
Quincy, IL 

Overview

Karthik Koduru is an Oncologist in Quincy, Illinois. Dr. Koduru is highly rated in 22 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Colonoscopy, and Endoscopy.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Oncology

Licenses

Internal Medicine in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

Quincy Medical Group Cancer Institute
3301 Broadway St, Quincy, IL 62301
Other Locations
Pittsfield Rural Health Affili
320 N Madison St, Pittsfield, IL 62363

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
MONARCH 2: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant With or Without Abemaciclib, a CDK4/6 Inhibitor, for Women With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Expertise in
14
conditions
Dr. Kevin Palka
Oncology
Expertise in
14
conditions
Dr. Kevin Palka
Oncology

Hannibal Regional Medical Group

6500 Hospital Dr, 
Hannibal, MO 
 (185.3 miles away)
573-629-3500
Languages Spoken:
English
See accepted insurances

Kevin Palka is an Oncologist in Hannibal, Missouri. Dr. Palka is highly rated in 14 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Prostate Cancer, Familial Prostate Cancer, and Bone Marrow Aspiration.

Expertise in
0
conditions
Dr. Celeste Miller
Oncology
Expertise in
0
conditions
Dr. Celeste Miller
Oncology

Memphis Medical Services

450 E Sigler Ave Ste A, 
Memphis, MO 
 (251.3 miles away)
660-465-2828
Languages Spoken:
English
See accepted insurances

Celeste Miller is an Oncologist in Memphis, Missouri. Her top areas of expertise are Cronkhite-Canada Disease, Attenuated Familial Adenomatous Polyposis, Juvenile Polyposis Syndrome, Peptic Ulcer, and Gastrectomy.

Frequently Asked Questions about Dr. Karthik Koduru

How do I make an appointment with Dr. Karthik Koduru?

You can book an appointment with Dr. Karthik Koduru by calling their office at 217-277-4070. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Karthik Koduru a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karthik Koduru is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Karthik Koduru specialize in?

While Dr. Karthik Koduru is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Karthik Koduru accept my insurance?

Dr. Karthik Koduru accepts most major insurance plans, including Aetna and Health Care Services Corporation. We recommend calling the office directly at 217-277-4070 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Koduru's expertise for a condition
ConditionClose
    View All 17 Advanced Conditions
    View All 93 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile